XORTX Therapeutics (XRTX) Beginning Cash Balance (2021 - 2026)
XORTX Therapeutics' (XRTX) quarterly Beginning Cash Balance came in at $864514.0 in Q1 2026, down 65.05% YoY from $2.5 million in Q1 2025, and down 65.05% on a QoQ basis from $2.5 million in Q1 2025.
XORTX Therapeutics (XRTX) Beginning Cash Balance (2021 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 6 years of Beginning Cash Balance data on file, last reported at $864514.0 in Q1 2026.
- Quarterly Beginning Cash Balance fell 65.05% year-over-year to $864514.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $864514.0 (down 65.05% YoY) and the FY2025 annual result came in at $2.5 million, down 28.25% from the prior year.
- Beginning Cash Balance slipped to $864514.0 in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $14.9 million in Q1 2022 to a low of $864514.0 in Q1 2026.
- A 5-year average of $6.4 million and a median of $3.4 million in 2024 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2022 — Beginning Cash Balance soared 10897.99% — and 2024, when it sank 66.96%.
- Tracing XRTX's Beginning Cash Balance over 5 years: stood at $14.9 million in 2022, then fell by 29.89% to $10.4 million in 2023, then slumped by 66.96% to $3.4 million in 2024, then dropped by 28.25% to $2.5 million in 2025, then slumped by 65.05% to $864514.0 in 2026.
- The last three Beginning Cash Balance figures came in at $864514.0 (Q1 2026), $2.5 million (Q1 2025), and $3.4 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 864,514.00 |
| Mar 31, 2026 | 864,514.00 |
| Mar 31, 2025 | 2.47 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Mar 31, 2024 | 3.45 Mn |
| Mar 31, 2024 | 3.45 Mn |
| Mar 31, 2023 | 10.43 Mn |
| Mar 31, 2023 | 10.43 Mn |
| Mar 31, 2022 | 14.88 Mn |
| Mar 31, 2022 | 14.88 Mn |
| Mar 31, 2021 | 135,321.07 |
| Mar 31, 2021 | 135,321.07 |